Cosmos Health Targets $200M Revenue Growth by 2029
CHICAGO, United States, May 26, 2026 Cosmos Health Inc., a diversified and vertically integrated global healthcare company, has released...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
CHICAGO, United States, May 26, 2026 Cosmos Health Inc., a diversified and vertically integrated global healthcare company, has released...
SPOKANE, Wash., May 7, 2026 LiT Biosciences, LLC announced the launch of LiT Protect, a patent-pending botanical dietary supplement...
IRVINE, Calif., April 08, 2026 iHerb Holdings, Inc., a leading global e-commerce platform for health and wellness products, has...
